HomeTMCI • NASDAQ
Treace Medical Concepts Inc
$7.30
Pre-market:
$7.30
(0.00%)0.00
Sarado: Ene 13, 4:09:39 AM GMT-5 · USD · NASDAQ · Disclaimer
StockSegurong nakalista sa US
Nakaraang pagsara
$7.57
Sakop ng araw
$7.16 - $7.42
Sakop ng taon
$3.92 - $15.98
Market cap
454.77M USD
Average na Volume
331.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
(USD)Set 2024Y/Y na pagbabago
Kita
45.09M10.62%
Gastos sa pagpapatakbo
51.27M1.36%
Net na kita
-15.36M12.33%
Net profit margin
-34.0720.75%
Kita sa bawat share
-0.2510.71%
EBITDA
-12.98M20.16%
Aktuwal na % ng binabayarang buwis
Kabuuang asset
Kabuuang sagutin
(USD)Set 2024Y/Y na pagbabago
Cash at mga panandaliang investment
82.80M-32.22%
Kabuuang asset
212.92M-11.41%
Kabuuang sagutin
108.02M5.38%
Kabuuang equity
104.91M
Natitirang share
62.30M
Presyo para makapag-book
4.51
Return on assets
-17.24%
Return on capital
-21.19%
Net change in cash
(USD)Set 2024Y/Y na pagbabago
Net na kita
-15.36M12.33%
Cash mula sa mga operasyon
-11.84M-24.48%
Cash mula sa pag-invest
5.76M25.36%
Cash mula sa financing
8.00K-94.97%
Net change in cash
-6.07M-27.62%
Malayang cash flow
-7.50M37.82%
Tungkol
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Itinatag
2014
Website
Mga Empleyado
516
Search
I-clear ang paghahanap
Isara ang paghahanap
Mga app ng Google
Pangunahing menu